Finance

Lists
Why is VANI up २.८८%?
Dive Deeper
VANI:NASDAQ
Vivani Medical Inc
US$ १.०७
+२.८८%
(+०.०३०) 1D
US$ १.०७
+०.०२% (+०.०००२०)
After hours
Closed: नोभेम्बर ६, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VANI...
Open
US$ १.०४
High
US$ १.१०
Low
US$ १.०४
Mkt. cap
९.६५ करोड
Avg. vol.
१.७२ लाख
Volume
२.६३ लाख
52-wk high
US$ १.६६
52-wk low
US$ ०.९२
EPS
-US$ ०.३६
Beta
२.५१
Shares outstanding
९.०२ करोड
No. of employees
४२
Open
US$ १.०४
High
US$ १.१०
Low
US$ १.०४
Mkt. cap
९.६५ करोड
Avg. vol.
१.७२ लाख
Volume
२.६३ लाख
52-wk high
US$ १.६६
52-wk low
US$ ०.९२
EPS
-US$ ०.३६
Beta
२.५१
Shares outstanding
९.०२ करोड
No. of employees
४२
News stories
From web sources and news partners
Yardeni QuickTakes
Yardeni QuickTakes
·
१ घण्टा पहिले
US MARKETS CALL: S&P 500 Valuation Dives As Earnings Soar
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
This Dividend King Yielding 2X the S&P 500 Looks Like a Buy in November.
24/7 Wall St.
24/7 Wall St.
·
१ घण्टा पहिले
The S&P 500 Just Had Its Worst Week Since the April 2025 Tariff Crash
About Vivani Medical Inc
CEO-
Employees४२
Founded२००९
Headquarters-
SectorHealth Care
Industry-
Websitevivani.com
Analyst ratings
Based on 2 analysts giving stock ratings to VANI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for VANI in the last 3 months.
Highest
Current US$ १.०७
US$ ४.०० (+२७३.८३%)
Average
US$ ४.०० (+२७३.८३%)
Lowest
US$ ४.०० (+२७३.८३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
US$ ४.००
+२७३.८%
08/18/2026
Jaeson Schmidt
Lake Street
Buy
Maintained
US$ ४.००
+२७३.८%
08/14/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ ३.५०
+२२७.१%
07/09/2026
Thomas Flaten
Lake Street
Buy
Initiated
US$ ४.००
+२७३.८%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४५.१९ लाख
४६.३० लाख
४३.९० लाख
४४.५६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२२.०६ लाख
२१.८० लाख
२४.२७ लाख
२४.१८ लाख
Operating expense
६७.२५ लाख
६८.१० लाख
६८.१७ लाख
६८.७४ लाख
Total operating expenses
६७.२५ लाख
६८.१० लाख
६८.१७ लाख
६८.७४ लाख
Operating income
-६७.२५ लाख
-६८.१० लाख
-६८.१७ लाख
-६८.७४ लाख
Other non operating income
१.९५ लाख
१.७७ लाख
३७.०० हजार
५.०४ लाख
EBT including unusual items
-६५.३० लाख
-६६.३३ लाख
-६७.८० लाख
-६३.७० लाख
EBT excluding unusual items
-६५.३० लाख
-६६.३३ लाख
-६७.८० लाख
-६३.७० लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६५.३० लाख
-६६.३३ लाख
-६७.८० लाख
-६३.७० लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-६६.२० लाख
-६६.९५ लाख
-६६.८७ लाख
-६७.४६ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू